Relieves bronchospasm. ANDA 72637, held by Sun Pharmaceutical Industries. Albuterol Sulfate.
As of Nov 21, 2026, ANDA 72637 (Albuterol Sulfate), held by Sun Pharmaceutical Industries, was first approved by FDA on Feb 1, 1989, with 17 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Albuterol tablets are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 1, 1989 | Original application | Approved | None posted |
| Albuterol SulfateEQ 4MG BASE · tablet;oral | Albuterol Sulfate | Rx |
| Albuterol SulfateEQ 2MG BASE · tablet;oral | Albuterol Sulfate | Rx |
| Dec 11, 2002 | Supplement 17Manufacturing | Approved | None posted |
| Jul 3, 2002 | Supplement 16Manufacturing | Approved | None posted |
| May 1, 2002 | Supplement 14Manufacturing | Approved | None posted |
| Mar 4, 2002 | Supplement 15Manufacturing | Approved | None posted |
| May 16, 2000 | Supplement 12Manufacturing | Approved | None posted |
| May 16, 2000 | Supplement 13Manufacturing | Approved | None posted |
| Jun 12, 1998 | Supplement 11Labeling | Approved | None posted |
| Dec 5, 1997 | Supplement 10Manufacturing | Approved | None posted |
| Feb 24, 1997 | Supplement 9Manufacturing | Approved | None posted |
| Jun 22, 1995 | Supplement 8Manufacturing | Approved | None posted |
| Jan 12, 1994 | Supplement 7Manufacturing | Approved | None posted |
| Oct 25, 1993 | Supplement 6Manufacturing | Approved | None posted |
| Feb 9, 1993 | Supplement 5Labeling | Approved | None posted |
| Nov 5, 1992 | Supplement 4Labeling | Approved | None posted |
| Feb 4, 1991 | Supplement 3Labeling | Approved | None posted |
| Aug 29, 1990 | Supplement 2Labeling | Approved | None posted |
| Mar 22, 1989 | Supplement 1Labeling | Approved | None posted |
| Feb 1, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters